The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.
For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community. For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.
It is the membership that makes the Institute.
How does it all work ?
The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.
The Board is made up of members who give their time freely to guide the future direction of the ICR.
The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.
The ICR exists to support our members through all stages of their careers. We do this, in part, by:
Tickets are NOW ON SALE for our Spring Ethics & GCP Forum at University College London on Friday 19th April. Lord O'Shaughnessy will be presenting…
Roughly half a year after Biogen’s $7.3 billion buyout of rare disease specialist Reata Pharmaceuticals, the companies’ blockbuster bid for Reata’s Fr…
The National Institute for Health and Care Research (NIHR) has awarded over £20m to eight new global health research projects to strengthen health ser…
AstraZeneca is working with the NHL to encourage people to “Get Body Checked Against Cancer.” The campaign is designed to encourage sports fans to ask…
Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented
The NHS has revealed that thousands of lives have been saved and around 1…
Jardiance development partners Eli Lilly and Boehringer Ingelheim say it takes two: two tests, to be exact, to find out about a patient’s kidney disea…
The world we’re living in is changing rapidly and the future of health is being profoundly shaped by several interconnected factors.
The media marketplace’s shifting dynamics have reached tectonic proportion with reshuffles at emergent platforms and effects of union strikes shaking …
By early December, the Food and Drug Administration will decide on approval of a genetic medicine for sickle cell disease, potentially offering people…
With the nights drawing in, Bausch Health is taking the plunge on the first-ever TV spot for its seasonal affective disorder (SAD) drug Aplenzin. The …
NPIP will transform medical research and provide better outcomes for patients
The Medicines Discovery Catapult (MDC), the Medical Research Council (MR…
Astellas’ mission to turn menopause drug Veozah into a major product is ratcheting up a gear, with the drugmaker hitting go on a TV spot centered on h…
In an era characterised by remarkable breakthroughs in drug discovery, development and bio…
The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the …
Pharma has changed a lot in recent y…
Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be …
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
MSD has revealed that the National Institute for Health and …
It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a …
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
The Norfolk and Norwich University Hospitals (NNUH) Urology…
To book via Eventbrite and see the full agenda visit our Website
If you have any questions please email office@icr-global.org
Reef Group and UBS Asset Management have gained approval to develop one of Europe’s largest life sciences campuses in Stevenage, UK.
The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken withou…
Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and developmen…
For those of us who use sophisticated digital tools every day, it’s easy to assume that technology always makes life easier. It doesn’t.
TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial.
The st…
ONLINE Course - Please email office@icr-glogal.org if you wish to book a place. Guest £550.00 ICR Member £450.00 ICR Acad...
Guest £550 - https://buy.stripe.com/bIYbLE7kIcI8co03cP Member £450 -&n...
<span style="font-size:12.0pt; font-family:"Calibri Light",sans-s...
The ICR Ethics & GCP Forum is the ICR's flagship event for Industry and Academia a...
Please email office@icr-global.org if you wish to book a place Guest £550.00 ICR Member £450.00 ICR Academic £350.00 ...
ONLINE Course - Please email office@icr-global.org if you wish to book a place Guest £550.00 ICR Member £450.00 ICR Acade...